Free Trial

Anteris Technologies Global Corp. (NASDAQ:AVR) Short Interest Update

Anteris Technologies Global logo with Medical background

Key Points

  • Anteris Technologies Global Corp. (NASDAQ:AVR) experienced a notable 60.2% increase in short interest in September, with a total of 1,580,000 shares short sold, representing about 4.4% of the company’s shares.
  • Institutional investors have significantly increased their holdings, with L1 Capital Pty Ltd raising their stake by 146.9% and JPMorgan Chase & Co. expanding theirs by 9,958.6% in recent quarters.
  • The company reported a loss of $0.58 per share in its latest quarterly earnings, missing analyst expectations, while analysts maintain an average rating of "Moderate Buy" with a price target of $16.50.
  • MarketBeat previews top five stocks to own in November.

Anteris Technologies Global Corp. (NASDAQ:AVR - Get Free Report) was the target of a significant growth in short interest during the month of September. As of September 30th, there was short interest totaling 1,580,000 shares, a growth of 60.2% from the September 15th total of 986,000 shares. Approximately 4.4% of the company's shares are short sold. Based on an average daily volume of 170,200 shares, the days-to-cover ratio is currently 9.3 days. Based on an average daily volume of 170,200 shares, the days-to-cover ratio is currently 9.3 days. Approximately 4.4% of the company's shares are short sold.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. L1 Capital Pty Ltd lifted its position in shares of Anteris Technologies Global by 146.9% in the first quarter. L1 Capital Pty Ltd now owns 6,886,480 shares of the company's stock valued at $25,067,000 after buying an additional 4,097,797 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of Anteris Technologies Global by 9,958.6% during the second quarter. JPMorgan Chase & Co. now owns 1,068,328 shares of the company's stock worth $4,049,000 after purchasing an additional 1,057,707 shares during the period. ADAR1 Capital Management LLC increased its stake in shares of Anteris Technologies Global by 59.4% during the first quarter. ADAR1 Capital Management LLC now owns 1,678,063 shares of the company's stock worth $6,108,000 after purchasing an additional 625,095 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Anteris Technologies Global by 154.3% in the 2nd quarter. Geode Capital Management LLC now owns 420,427 shares of the company's stock valued at $1,593,000 after purchasing an additional 255,088 shares in the last quarter. Finally, Marex Group plc acquired a new stake in shares of Anteris Technologies Global in the 2nd quarter valued at $641,000.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a "sell (e+)" rating on shares of Anteris Technologies Global in a research note on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Anteris Technologies Global presently has an average rating of "Moderate Buy" and an average price target of $16.50.

Get Our Latest Report on AVR

Anteris Technologies Global Stock Up 7.1%

AVR stock opened at $6.35 on Wednesday. The business has a 50-day moving average of $4.52 and a 200-day moving average of $4.07. Anteris Technologies Global has a fifty-two week low of $2.34 and a fifty-two week high of $8.79.

Anteris Technologies Global (NASDAQ:AVR - Get Free Report) last posted its quarterly earnings data on Monday, August 11th. The company reported ($0.58) earnings per share for the quarter, missing the consensus estimate of ($0.53) by ($0.05). The firm had revenue of $0.62 million during the quarter, compared to the consensus estimate of $0.58 million. On average, equities analysts predict that Anteris Technologies Global will post -2.66 EPS for the current fiscal year.

Anteris Technologies Global Company Profile

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anteris Technologies Global Right Now?

Before you consider Anteris Technologies Global, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list.

While Anteris Technologies Global currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.